ERBB2 and breast carcinoma: In an attempt to develop radiosensitivity signatures intrinsic radiosensitivity ranged from 17 to 77% in 16 breast cancer cell lines (5 luminal, 4 basal A, 4 basal B, 3 HER2/neu amplified) which were tested in radiation clonogenic assays (RSS).